CLS2901C

· CellSeed Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CLS2901C, covering 2025-11-24 to 2025-11-24. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Study of CLS2901C in Patients With Osteoarthritis of the Knee [Phase 3]